Coastal Bridge Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Coastal Bridge Advisors’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-11,970	Closed	-$134K	–	185
2022 Q4	$134K	Hold	11,970	–	–	0.04%	153
2022 Q3	$67K	Hold	11,970	–	–	0.02%	168
2022 Q2	$52K	Hold	11,970	–	–	0.02%	155
2022 Q1	$139K	Sell	11,970 -7,260	-38%	-$86.4K	0.03%	155
2021 Q4	$356K	Buy	19,230 +7,260	+61%	+$92.1K	0.07%	130
2021 Q3	$142K	Buy	+11,970	New	+$174K	0.03%	136
2020 Q3	–	Sell	-7,260	Closed	-$210K	–	157
2020 Q2	$210K	Buy	+7,260	New	+$219K	0.07%	117

Other funds holding OYST

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Coastal Bridge Advisors's OYST Position: Q1 2023 in Review

Coastal Bridge Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 11,970 shares — an estimated $134K sold.

Coastal Bridge Advisors first reported a position in OYST in Q2 2020 and held it in 7 quarters. The position peaked at $356K in Q4 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

Coastal Bridge Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Coastal Bridge Advisors sold 11,970 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $134K.
Coastal Bridge Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Coastal Bridge Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $356K in Q4 2021.
1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Coastal Bridge Advisors's 13F filing for Q1 2023, filed 15 May 2023.